On 9th June 2026, TaBriX joined the Venture Road UK initiative in London, connecting with an exciting network of high-growth life sciences and deep tech companies from across the UK. The programme provided an opportunity to engage with investors, industry… Read More »TaBriX joins the Venture Road UK initiative in London
Professor Lydia Tabernero, founder of TaBriX, joined innovators, founders and investors at Venture Cafe Manchester, on 7 May 2026, presenting as part of an event organised by Nucleate. The session brought together members of Manchester’s growing life sciences and biotech community, providing… Read More »TabriX presents at the Venture Café, Manchester, organised by Nucleate
TaBriX founder Dr Lydia Tabernero recently spoke at the Bionow BioInfect 2026 conference, held at Alderley Park, one of the UK’s leading life sciences campuses. BioInfect is Bionow’s flagship conference focused on antimicrobial resistance (AMR) and infection innovation, bringing together experts from research, clinical practice, biotech,… Read More »Bionow BioInfect 2026, Alderley Park
TaBriX was proud to be represented at BIO-Europe Spring 2026, where founder Dr Lydia Tabernero spoke at one of Europe’s leading life sciences partnering events. Held in Lisbon from 23–25 March 2026, BIO-Europe Spring brings together more than 3,700 leaders, innovators, investors and business development… Read More »Dr Lydia Tabernero Represents TaBriX at BIO-Europe Spring 2026 in Lisbon
TaBriX has welcomed their first private investment to fund their work.
TaBriX has received an award from the European Regional Development Fund Research and Innovation Health Accelerator Programme.
TaBriX has recently received a Proof-of-Principle award from the University of Manchester Innovation Factory to support the completion of the lead optimisation programme of TaBriX assets.
TaBriX has received an award for €10,000 from INCATE, an Incubator for AntibacterialTherapies in Europe that supports innovation to fight drug-resistant bacterial infections.
Tuberculosis Pipeline Landscape Analysis of 38+ Companies by DelveInsight
TaBriX has received an award from the Manchester Health Innovation Accelerator Project ERDF for SMEs.